Doxorubicin (Dox) remains an essential drug in several anticancer regimens even though its use is associated with severe cardiotoxic side effects that persist after drug withdrawal and can lead to heart failure. In addition to cardiomyocytes, damaged cardiac endothelial cells are a culprit of Dox-induced cardiotoxicity. We show that a brief exposure of endothelial cells to low Dox concentrations leads to long-lasting effects that include cellular senescence and downregulation of VEGFR2, crucial for endothelial cell activation. Mechanistically, Dox represses global protein synthesis by inhibiting mTOR. Senescence and downregulation of VEGFR2 in endothelial cells might participate in Dox-induced cardiotoxicity. View this paper